Compare Tata Nifty MidSmall Healthcare Index Fund vs SBI Healthcare Opportunities Fund
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
1.1
1.93
NAV
₹12.22
₹414.60
Fund Started
08 Apr 2024
04 Jun 1999
Fund Size
₹158.34 Cr
₹4076.67 Cr
Exit Load
Exit load of 0.25%, if redeemed within 15 days.
Exit load of 0.50% if redeemed within 15 days
1 Year
8.84%
5.07%
3 Year
-
24.41%
5 Year
-
16.54%
Equity
101.41%
97.00%
Cash
-1.41%
2.93%
Top 10 Holdings
Lupin Ltd. | 10.41% |
Fortis Healthcare Ltd. | 9.17% |
Laurus Labs Ltd. | 7.80% |
Aurobindo Pharma Ltd. | 6.37% |
Alkem Laboratories Ltd. | 6.16% |
Glenmark Pharmaceuticals Ltd. | 6.00% |
Biocon Ltd. | 5.19% |
Mankind Pharma Ltd. | 4.74% |
Ipca Laboratories Ltd. | 3.97% |
Krishna Institute of Medical Sciences Ltd | 3.43% |
Sun Pharmaceutical Industries Ltd. | 10.65% |
Divi's Laboratories Ltd. | 7.55% |
Apollo Hospitals Enterprise Ltd. | 5.76% |
Max Healthcare Institute Ltd. | 4.82% |
Acutaas Chemicals Ltd. | 4.77% |
Torrent Pharmaceuticals Ltd. | 4.25% |
Lupin Ltd. | 4.23% |
Aster DM Healthcare Ltd. | 3.85% |
Biocon Ltd. | 3.59% |
Laurus Labs Ltd. | 3.48% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to provide returns, before expenses, that are in line with the performance of Nifty MidSmall Healthcare Index (TRI), subject to tracking error.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
08 Apr 2024
04 Jun 1999
